Leadership Guiding the future of nuclear medicine

Curium’s leadership team combines scientific, operational, and commercial expertise to guide the company’s strategy and long-term growth in nuclear medicine. With deep industry experience and a shared commitment to innovation, our leaders help expand access to life-changing radiodiagnostic and radiotherapeutic solutions for patients around the world.

Renaud Dehareng

CEO Curium Group

Mike Patterson

CEO Curium North America

Ciril Faia

CEO Curium International

Chaitanya Tatineni

CEO Curium Biopharma

Mathilde Marret

Chief Strategy Officer

Sakir Mutevelic

Chief Medical Officer

Xavier Defourt

Chief Legal Officer

Joel Morales

Chief Financial Officer

Paul Gronland

Chief Projects Officer

Brendan Hill

Chief Talent Officer

Marla Franz

Chief People Officer